Tetracycline-class Antibacterial [EPC]

Tetracycline-class Antibacterial [EPC] was reported 7864 times

Drugs of the Tetracycline-class Antibacterial [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 DRUG CLEARANCE 4 0.4444
1 ANTIMICROBIAL SUSCEPTIBILITY TEST INTERMEDIATE 4 0.3636
2 EOSINOPHIL COUNT NORMAL 3 0.2143
3 FLAVOBACTERIUM INFECTION 9 0.2045
4 GALLSTONE ILEUS 6 0.1364
5 HYPOFIBRINOGENAEMIA 99 0.0998
6 MYCOBACTERIUM ABSCESSUS INFECTION 71 0.0993
7 ACUTE GRAFT VERSUS HOST DISEASE ORAL 3 0.0968
8 BLOOD FIBRINOGEN DECREASED 104 0.0911
9 ADJUSTED CALCIUM DECREASED 9 0.0849
10 ANTIBIOTIC ASSOCIATED COLITIS 3 0.0811
11 HAEMORRHAGIC PNEUMONIA 5 0.0806
12 PARASPINAL ABSCESS 12 0.0774
13 PURPURA NON-THROMBOCYTOPENIC 6 0.0723
14 ACINETOBACTER BACTERAEMIA 13 0.0691
15 ACINETOBACTER INFECTION 73 0.0667
16 HAEMORRHAGIC NECROTIC PANCREATITIS 5 0.0667
17 CUTANEOUS SPOROTRICHOSIS 3 0.0625
18 DYSBIOSIS 47 0.0572
19 PROCALCITONIN DECREASED 4 0.0571
20 BILE ACIDS INCREASED 10 0.0565
21 GEOTRICHUM INFECTION 11 0.0521
22 ATYPICAL MYCOBACTERIUM TEST POSITIVE 5 0.0515
23 BILOMA 7 0.0496
24 HAEMOSTASIS 8 0.0491
25 MYCOBACTERIUM CHELONAE INFECTION 35 0.0474
26 SUPERINFECTION FUNGAL 4 0.0471
27 THROMBIN TIME PROLONGED 11 0.0445
28 MYCOBACTERIAL PERITONITIS 4 0.0421
29 ACINETOBACTER TEST POSITIVE 8 0.0412
30 TONSILLITIS BACTERIAL 8 0.0412
31 MORGANELLA INFECTION 12 0.0410
32 TRICHOSPORON INFECTION 13 0.0321
33 COAGULATION TIME PROLONGED 45 0.0291
34 STAPHYLOCOCCAL SCALDED SKIN SYNDROME 6 0.0267
35 OTOTOXICITY 46 0.0249
36 KLEBSIELLA BACTERAEMIA 23 0.0242
37 PATHOGEN RESISTANCE 219 0.0240
38 VANCOMYCIN INFUSION REACTION 9 0.0239
39 NEUROMUSCULAR BLOCKADE 5 0.0223
40 HEPATIC INFARCTION 8 0.0212
41 KLEBSIELLA INFECTION 103 0.0203
42 DRUG DOSE TITRATION NOT PERFORMED 36 0.0196
43 MEDIASTINITIS 11 0.0190
44 PENILE OEDEMA 6 0.0184
45 COAGULATION FACTOR DECREASED 5 0.0183
46 OSTEOMYELITIS BACTERIAL 5 0.0182
47 ACID BASE BALANCE ABNORMAL 4 0.0179
48 DISSEMINATED MUCORMYCOSIS 7 0.0178
49 INFUSION SITE PHLEBITIS 4 0.0175
50 EOSINOPHILIC PNEUMONIA ACUTE 15 0.0173
51 ACOUSTIC NEUROMA 7 0.0171
52 CITROBACTER INFECTION 7 0.0163
53 INFECTIVE EXACERBATION OF BRONCHIECTASIS 5 0.0163
54 PROCALCITONIN INCREASED 19 0.0162
55 ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT 5 0.0162
56 COMA HEPATIC 12 0.0162
57 ICHTHYOSIS 4 0.0159
58 DEHISCENCE 3 0.0159
59 MITOCHONDRIAL TOXICITY 13 0.0158
60 DYSSOMNIA 3 0.0156
61 COOMBS NEGATIVE HAEMOLYTIC ANAEMIA 3 0.0154
62 KLEBSIELLA TEST POSITIVE 10 0.0154
63 ENTEROCOCCAL INFECTION 74 0.0153
64 MULTIPLE-DRUG RESISTANCE 47 0.0151
65 SPLENIC ABSCESS 6 0.0147
66 STENOTROPHOMONAS INFECTION 20 0.0147
67 SUPERINFECTION 22 0.0147
68 TRICHOGLOSSIA 6 0.0146
69 MYCOBACTERIUM HAEMOPHILUM INFECTION 4 0.0140
70 BURKHOLDERIA CEPACIA COMPLEX INFECTION 4 0.0140
71 BILIRUBIN CONJUGATED INCREASED 32 0.0137
72 PANCREATIC INJURY 4 0.0131
73 COAGULOPATHY 218 0.0131
74 MYCOBACTERIAL INFECTION 22 0.0128
75 FUNGAEMIA 20 0.0127
76 EXTRAVASATION BLOOD 3 0.0126
77 VITAMIN K DEFICIENCY 5 0.0124
78 RESPIRATORY MUSCLE WEAKNESS 4 0.0123
79 BONE ABSCESS 5 0.0123
80 HYPOCAPNIA 5 0.0120
81 RESPIRATORY TRACT HAEMORRHAGE 7 0.0117
82 PNEUMONIA PSEUDOMONAL 17 0.0111
83 ABSCESS BACTERIAL 4 0.0110
84 LUNG INFECTION PSEUDOMONAL 6 0.0108
85 PROTHROMBIN LEVEL DECREASED 10 0.0106
86 URINARY TRACT INFECTION FUNGAL 6 0.0105
87 FIBRIN DEGRADATION PRODUCTS INCREASED 3 0.0101
88 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 51 0.0101
89 LABELLED DRUG-FOOD INTERACTION MEDICATION ERROR 5 0.0100
90 DRUG RESISTANCE 255 0.0099
91 HYPOGONADISM 10 0.0099
92 TOOTH DISCOLOURATION 29 0.0099
93 SCROTAL OEDEMA 7 0.0098
94 EPIDERMOLYSIS BULLOSA 3 0.0097
95 AMYLASE INCREASED 35 0.0095
96 PULMONARY MUCORMYCOSIS 5 0.0095
97 PSEUDOMONAL BACTERAEMIA 8 0.0094
98 MYCOBACTERIUM AVIUM COMPLEX INFECTION 25 0.0093
99 COAGULATION FACTOR V LEVEL DECREASED 3 0.0092
100 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 19 0.0089
101 OEDEMATOUS PANCREATITIS 5 0.0089
102 PSEUDOMONAS INFECTION 76 0.0089
103 PNEUMONIA KLEBSIELLA 16 0.0087
104 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 33 0.0086
105 PANCREATITIS HAEMORRHAGIC 4 0.0086
106 RENAL ABSCESS 7 0.0085
107 DEAFNESS NEUROSENSORY 28 0.0085
108 CYTOMEGALOVIRUS HEPATITIS 3 0.0085
109 DELAYED GRAFT FUNCTION 6 0.0084
110 FUNGAL SEPSIS 7 0.0084
111 PROTEUS INFECTION 6 0.0084
112 BACTERIAL SEPSIS 27 0.0083
113 MEGACOLON 13 0.0083
114 PANCREATITIS NECROTISING 19 0.0083
115 CEREBRAL ASPERGILLOSIS 5 0.0081
116 ABDOMINAL INFECTION 20 0.0078
117 C-REACTIVE PROTEIN DECREASED 5 0.0077
118 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 25 0.0076
119 ENTEROCOCCAL BACTERAEMIA 8 0.0075
120 LIPASE INCREASED 57 0.0074
121 MYASTHENIA GRAVIS CRISIS 11 0.0074
122 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 3 0.0074
123 SPUTUM CULTURE POSITIVE 6 0.0074
124 PANCREATITIS ACUTE 162 0.0072
125 KLEBSIELLA SEPSIS 8 0.0071
126 GLUCOCORTICOID DEFICIENCY 3 0.0071
127 ATYPICAL MYCOBACTERIAL INFECTION 10 0.0071
128 GRAFT VERSUS HOST DISEASE IN LIVER 5 0.0070
129 BLOOD BILIRUBIN UNCONJUGATED INCREASED 5 0.0069
130 SUSPECTED OFF LABEL USE 31 0.0069
131 GRAFT VERSUS HOST DISEASE IN SKIN 15 0.0068
132 ALVEOLAR PROTEINOSIS 4 0.0068
133 PSEUDOMEMBRANOUS COLITIS 15 0.0067
134 PROTHROMBIN TIME PROLONGED 40 0.0067
135 DEBRIDEMENT 5 0.0065
136 PROTHROMBIN TIME RATIO DECREASED 4 0.0064
137 SUPERINFECTION BACTERIAL 5 0.0063
138 PSEUDOMONAL SEPSIS 11 0.0063
139 SKIN BACTERIAL INFECTION 5 0.0062
140 RED BLOOD CELLS URINE POSITIVE 6 0.0062
141 CARDIAC VALVE VEGETATION 3 0.0062
142 ENTEROCOCCUS TEST POSITIVE 4 0.0062
143 ABDOMINAL WALL ABSCESS 4 0.0062
144 ENTEROCOCCAL SEPSIS 5 0.0062
145 SYSTEMIC CANDIDA 15 0.0060
146 ACUTE LUNG INJURY 7 0.0059
147 LIVER ABSCESS 19 0.0059
148 CLOSTRIDIUM DIFFICILE COLITIS 62 0.0058
149 PERITONEAL HAEMORRHAGE 8 0.0058
150 BACTERAEMIA 68 0.0057
151 BRONCHIECTASIS 38 0.0056
152 SEPTIC SHOCK 245 0.0056
153 JARISCH-HERXHEIMER REACTION 4 0.0056
154 AUTOSCOPY 3 0.0056
155 BRONCHOSTENOSIS 3 0.0055
156 PANCREATIC ENZYMES INCREASED 8 0.0055
157 SERRATIA INFECTION 4 0.0054
158 DRUG CLEARANCE DECREASED 7 0.0054
159 ASPERGILLUS INFECTION 35 0.0053
160 WOUND INFECTION STAPHYLOCOCCAL 9 0.0052
161 COAGULATION TEST ABNORMAL 4 0.0052
162 METHAEMOGLOBINAEMIA 12 0.0052
163 EYELID RASH 5 0.0051
164 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 4 0.0051
165 ENDOCARDITIS 26 0.0051
166 DIAPHRAGMATIC PARALYSIS 3 0.0050
167 CHRONIC RESPIRATORY FAILURE 6 0.0050
168 BLOOD BILIRUBIN INCREASED 134 0.0050
169 VESTIBULAR DISORDER 6 0.0049
170 ESCHERICHIA INFECTION 40 0.0049
171 RENAL INFARCT 7 0.0048
172 ENTEROBACTER INFECTION 8 0.0048
173 MULTI-ORGAN FAILURE 80 0.0046
174 MULTI-ORGAN DISORDER 9 0.0046
175 INCORRECT PRODUCT ADMINISTRATION DURATION 98 0.0045
176 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 12 0.0045
177 CHOLESTATIC LIVER INJURY 10 0.0045
178 HYPERLACTACIDAEMIA 12 0.0045
179 MYOCARDIAL INJURY 5 0.0044
180 SYSTEMIC MYCOSIS 5 0.0043
181 PROTEIN TOTAL DECREASED 16 0.0042
182 MUCORMYCOSIS 11 0.0042
183 HYPOPROTEINAEMIA 8 0.0042
184 ESCHERICHIA TEST POSITIVE 5 0.0042
185 HEPATITIS CHOLESTATIC 25 0.0041
186 HYPOCOAGULABLE STATE 4 0.0041
187 CYCLIC VOMITING SYNDROME 3 0.0041
188 CONTINUOUS HAEMODIAFILTRATION 4 0.0041
189 CANDIDA INFECTION 69 0.0041
190 NOSOCOMIAL INFECTION 9 0.0041
191 BACTERIAL INFECTION 75 0.0040
192 MULTIPLE ORGAN DYSFUNCTION SYNDROME 113 0.0040
193 NEPHROPATHY TOXIC 44 0.0039
194 HAEMATOLOGICAL MALIGNANCY 11 0.0039
195 SOFT TISSUE INFECTION 7 0.0038
196 LUNG ABSCESS 8 0.0038
197 HAEMODYNAMIC INSTABILITY 29 0.0038
198 PNEUMONIA FUNGAL 15 0.0038
199 BRONCHOPULMONARY ASPERGILLOSIS 29 0.0037
200 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 96 0.0037
201 STRONGYLOIDIASIS 6 0.0037
202 SPUTUM INCREASED 8 0.0037
203 JAUNDICE CHOLESTATIC 13 0.0037
204 INFUSION SITE RASH 5 0.0036
205 BLOOD UREA INCREASED 61 0.0036
206 HYPERTRANSAMINASAEMIA 25 0.0036
207 CHOLESTASIS 67 0.0035
208 GINGIVAL ERYTHEMA 3 0.0035
209 EPIDIDYMITIS 4 0.0034
210 SPLENIC INFARCTION 6 0.0034
211 TRANSAMINASES INCREASED 76 0.0034
212 HYPERTRIGLYCERIDAEMIA 20 0.0034
213 INCISION SITE PAIN 4 0.0034
214 LIVER INJURY 83 0.0034
215 INTRA-ABDOMINAL HAEMORRHAGE 8 0.0034
216 PNEUMOCYSTIS JIROVECII INFECTION 4 0.0033
217 CANDIDA SEPSIS 3 0.0033
218 DIABETES INSIPIDUS 8 0.0033
219 PNEUMOMEDIASTINUM 6 0.0033
220 HYPERCAPNIA 10 0.0033
221 HEPATOTOXICITY 73 0.0033
222 DISORGANISED SPEECH 6 0.0033
223 WOUND HAEMORRHAGE 12 0.0032
224 RENAL TUBULAR DISORDER 9 0.0032
225 HEPATIC FUNCTION ABNORMAL 119 0.0032
226 PERIPHERAL SENSORIMOTOR NEUROPATHY 4 0.0032
227 BLOOD ALKALINE PHOSPHATASE INCREASED 79 0.0032
228 NEUTROPHIL PERCENTAGE INCREASED 4 0.0032
229 COR PULMONALE 3 0.0031
230 ANURIA 27 0.0031
231 METABOLIC ALKALOSIS 5 0.0031
232 SINUS ARRHYTHMIA 4 0.0031
233 INFLAMMATORY MARKER INCREASED 15 0.0030
234 SKIN HYPERPIGMENTATION 26 0.0030
235 BLOOD ALBUMIN DECREASED 24 0.0030
236 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 15 0.0030
237 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 7 0.0030
238 FALSE POSITIVE INVESTIGATION RESULT 3 0.0030
239 POSTOPERATIVE WOUND INFECTION 20 0.0030
240 PANCREATITIS 155 0.0029
241 EFFUSION 4 0.0029
242 ELECTROCARDIOGRAM QT PROLONGED 103 0.0029
243 PNEUMONIA BACTERIAL 26 0.0028
244 RESPIRATORY ACIDOSIS 11 0.0028
245 GRAFT VERSUS HOST DISEASE 20 0.0028
246 YELLOW SKIN 13 0.0028
247 OCULAR ICTERUS 12 0.0028
248 HEPATIC FAILURE 81 0.0027
249 WOUND DEHISCENCE 9 0.0027
250 CLOSTRIDIAL INFECTION 9 0.0027
251 LUNG OPACITY 7 0.0027
252 PULSELESS ELECTRICAL ACTIVITY 11 0.0026
253 MECHANICAL VENTILATION 5 0.0026
254 MYOGLOBIN BLOOD INCREASED 4 0.0026
255 DRUG-INDUCED LIVER INJURY 82 0.0026
256 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 4 0.0026
257 HYPERBILIRUBINAEMIA 27 0.0026
258 SHOCK HAEMORRHAGIC 21 0.0026
259 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 14 0.0026
260 ESCHERICHIA BACTERAEMIA 6 0.0025
261 STAPHYLOCOCCAL INFECTION 84 0.0025
262 EOSINOPHILIC PNEUMONIA 8 0.0025
263 ABDOMINAL ADHESIONS 8 0.0025
264 FIBRIN D DIMER INCREASED 9 0.0025
265 INHIBITORY DRUG INTERACTION 4 0.0025
266 EMPYEMA 5 0.0025
267 ABSCESS 40 0.0025
268 ASPARTATE AMINOTRANSFERASE INCREASED 133 0.0025
269 ABDOMINAL ABSCESS 11 0.0025
270 ENCEPHALITIS VIRAL 3 0.0025
271 ILEUS PARALYTIC 11 0.0025
272 CARDIOVASCULAR INSUFFICIENCY 4 0.0025
273 SEPSIS 274 0.0025
274 OPTIC ATROPHY 4 0.0025
275 THROMBOCYTOPENIA 274 0.0024
276 HYPOALBUMINAEMIA 19 0.0024
277 ARTHRITIS BACTERIAL 10 0.0024
278 ACUTE HEPATIC FAILURE 33 0.0024
279 INTESTINAL ISCHAEMIA 13 0.0024
280 DEAFNESS UNILATERAL 13 0.0024
281 NEUTROPHIL COUNT INCREASED 24 0.0023
282 BLOOD AMYLASE INCREASED 4 0.0023
283 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 127 0.0023
284 GAMMA-GLUTAMYLTRANSFERASE INCREASED 51 0.0023
285 DEAFNESS 60 0.0023
286 NECROTISING FASCIITIS 8 0.0023
287 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 17 0.0023
288 AZOTAEMIA 9 0.0023
289 HYPERNATRAEMIA 11 0.0022
290 HEPATIC ENZYME ABNORMAL 11 0.0022
291 ALANINE AMINOTRANSFERASE INCREASED 135 0.0022
292 HYPERURICAEMIA 9 0.0022
293 GENERALISED OEDEMA 27 0.0022
294 AGRANULOCYTOSIS 40 0.0021
295 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 13 0.0021
296 CULTURE URINE POSITIVE 3 0.0021
297 TRANSPLANT REJECTION 17 0.0021
298 FORCED EXPIRATORY VOLUME DECREASED 6 0.0021
299 EOSINOPHILIA 37 0.0021
300 LONG QT SYNDROME 5 0.0021
301 SUPRAVENTRICULAR EXTRASYSTOLES 7 0.0021
302 DISSEMINATED INTRAVASCULAR COAGULATION 29 0.0021
303 TONGUE DISCOLOURATION 9 0.0021
304 CONCOMITANT DISEASE PROGRESSION 4 0.0020
305 WOUND SECRETION 8 0.0020
306 BILIARY DILATATION 3 0.0020
307 TOXIC EPIDERMAL NECROLYSIS 31 0.0020
308 WOUND COMPLICATION 7 0.0020
309 PNEUMONIA STAPHYLOCOCCAL 4 0.0020
310 METABOLIC ENCEPHALOPATHY 6 0.0020
311 CREATININE RENAL CLEARANCE DECREASED 8 0.0020
312 DERMATITIS EXFOLIATIVE 10 0.0020
313 ORGAN FAILURE 8 0.0020
314 HAEMORRHAGIC DIATHESIS 7 0.0020
315 DEVICE RELATED INFECTION 30 0.0019
316 HEPATOSPLENOMEGALY 5 0.0019
317 CONCOMITANT DISEASE AGGRAVATED 12 0.0019
318 CACHEXIA 10 0.0019
319 ACUTE RESPIRATORY DISTRESS SYNDROME 34 0.0019
320 GASTROINTESTINAL TOXICITY 9 0.0019
321 CYTOMEGALOVIRUS INFECTION 31 0.0019
322 HYPERPHOSPHATAEMIA 4 0.0019
323 STAPHYLOCOCCAL BACTERAEMIA 8 0.0018
324 TREATMENT FAILURE 152 0.0018
325 MACULE 5 0.0018
326 CARDIAC FAILURE ACUTE 12 0.0018
327 SKIN MASS 12 0.0018
328 PRODUCT PACKAGE ASSOCIATED INJURY 4 0.0018
329 EPIGASTRIC DISCOMFORT 7 0.0018
330 PLATELET COUNT DECREASED 189 0.0018
331 BONE MARROW FAILURE 36 0.0018
332 DEAFNESS BILATERAL 3 0.0018
333 GAZE PALSY 3 0.0018
334 ATELECTASIS 17 0.0018
335 ECCHYMOSIS 12 0.0017
336 HERPES VIRUS INFECTION 10 0.0017
337 ESCHERICHIA SEPSIS 5 0.0017
338 EXTREMITY NECROSIS 3 0.0017
339 IMPLANT SITE INFECTION 4 0.0017
340 PULMONARY PAIN 5 0.0017
341 CLOSTRIDIUM DIFFICILE INFECTION 37 0.0017
342 HAEMOPTYSIS 47 0.0017
343 BLOOD CULTURE POSITIVE 5 0.0017
344 DERMATITIS ALLERGIC 21 0.0017
345 KIDNEY TRANSPLANT REJECTION 8 0.0017
346 ACUTE RESPIRATORY FAILURE 32 0.0017
347 MIXED LIVER INJURY 5 0.0017
348 LEUKOCYTOSIS 30 0.0017
349 ORAL INTAKE REDUCED 4 0.0017
350 ESCHERICHIA URINARY TRACT INFECTION 7 0.0016
351 PROSTATITIS 5 0.0016
352 CYSTIC FIBROSIS 9 0.0016
353 RASH MACULO-PAPULAR 36 0.0016
354 STREPTOCOCCAL INFECTION 9 0.0016
355 BRONCHOSPASM 23 0.0016
356 RESPIRATORY FAILURE 117 0.0016
357 OSTEOMYELITIS 29 0.0016
358 PULMONARY FUNCTION TEST DECREASED 7 0.0016
359 BLOOD BICARBONATE DECREASED 3 0.0016
360 PNEUMOTHORAX 25 0.0016
361 DRUG LEVEL INCREASED 26 0.0016
362 APNOEA 12 0.0015
363 PRODUCT PACKAGING DIFFICULT TO OPEN 4 0.0015
364 VENOUS THROMBOSIS 6 0.0015
365 LISTLESS 5 0.0015
366 RENAL IMPAIRMENT 126 0.0015
367 DEVICE RELATED SEPSIS 3 0.0015
368 POTENTIATING DRUG INTERACTION 5 0.0015
369 ANAL ABSCESS 8 0.0015
370 PULMONARY MASS 22 0.0015
371 GENERAL PHYSICAL CONDITION ABNORMAL 10 0.0015
372 LUNG INFILTRATION 13 0.0015
373 CYTOPENIA 18 0.0015
374 HYDROCEPHALUS 8 0.0015
375 ENCEPHALOPATHY 36 0.0015
376 HYPOVOLAEMIC SHOCK 7 0.0015
377 SUBCUTANEOUS ABSCESS 7 0.0015
378 TYPE IV HYPERSENSITIVITY REACTION 4 0.0015
379 PUSTULAR PSORIASIS 5 0.0015
380 JAUNDICE 39 0.0014
381 HYPOGLYCAEMIA 70 0.0014
382 INTERNATIONAL NORMALISED RATIO INCREASED 41 0.0014
383 MALNUTRITION 16 0.0014
384 ENDOTRACHEAL INTUBATION 4 0.0014
385 BREATH SOUNDS ABNORMAL 7 0.0014
386 PAPULE 10 0.0014
387 HYPERPYREXIA 6 0.0014
388 LUNG TRANSPLANT 5 0.0014
389 HEPATOCELLULAR INJURY 20 0.0014
390 HAEMORRHAGE SUBCUTANEOUS 5 0.0014
391 PURULENT DISCHARGE 6 0.0014
392 ACUTE MYELOID LEUKAEMIA RECURRENT 3 0.0014
393 SHOCK 32 0.0014
394 MYELOSUPPRESSION 50 0.0014
395 GLOMERULAR FILTRATION RATE DECREASED 17 0.0014
396 LEUKOPENIA 69 0.0014
397 BLOOD CREATININE INCREASED 90 0.0014
398 ELECTROLYTE IMBALANCE 16 0.0014
399 LIVER FUNCTION TEST ABNORMAL 40 0.0014
400 THROMBOCYTOSIS 5 0.0014
401 CLOSTRIDIUM TEST POSITIVE 3 0.0014
402 LYMPHOCYTE COUNT DECREASED 24 0.0014
403 DRUG ERUPTION 24 0.0014
404 HYPOPHOSPHATAEMIA 10 0.0014
405 DECUBITUS ULCER 11 0.0013
406 C-REACTIVE PROTEIN INCREASED 49 0.0013
407 BACTERIAL TEST POSITIVE 3 0.0013
408 HEPATIC ENZYME INCREASED 91 0.0013
409 FEAR OF DEATH 3 0.0013
410 DISTRIBUTIVE SHOCK 3 0.0013
411 COMPUTERISED TOMOGRAM ABNORMAL 3 0.0013
412 TACHYPNOEA 18 0.0013
413 EOSINOPHIL COUNT INCREASED 11 0.0013
414 RHABDOMYOLYSIS 55 0.0013
415 METABOLIC ACIDOSIS 42 0.0013
416 HYPERKALAEMIA 46 0.0013
417 ACUTE GRAFT VERSUS HOST DISEASE 6 0.0013
418 RENAL FAILURE CHRONIC 10 0.0013
419 OFF LABEL USE 1136 0.0013
420 BRAIN DEATH 4 0.0013
421 TOXIC SKIN ERUPTION 13 0.0013
422 ACUTE KIDNEY INJURY 196 0.0013
423 TINNITUS 58 0.0013
424 ENTERITIS 8 0.0012
425 TENDERNESS 13 0.0012
426 ACUTE PULMONARY OEDEMA 7 0.0012
427 PERONEAL NERVE PALSY 7 0.0012
428 HEPATITIS ACUTE 8 0.0012
429 WHITE BLOOD CELL COUNT INCREASED 47 0.0012
430 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 5 0.0012
431 HEPARIN-INDUCED THROMBOCYTOPENIA 6 0.0012
432 BLOOD CREATINE PHOSPHOKINASE INCREASED 35 0.0012
433 PERITONITIS 25 0.0012
434 LACTIC ACIDOSIS 39 0.0012
435 NEUROTOXICITY 21 0.0012
436 SKIN DISCOLOURATION 55 0.0012
437 HAEMODIALYSIS 10 0.0012
438 TOXIC ENCEPHALOPATHY 6 0.0012
439 HEPATIC CYST 4 0.0012
440 FACIAL PARALYSIS 10 0.0012
441 HAEMOLYSIS 9 0.0012
442 REGURGITATION 4 0.0012
443 LIVER FUNCTION TEST INCREASED 25 0.0012
444 PANCYTOPENIA 65 0.0012
445 LEFT VENTRICULAR FAILURE 4 0.0012
446 FUNCTIONAL GASTROINTESTINAL DISORDER 4 0.0012
447 HYPOMAGNESAEMIA 16 0.0011
448 THROMBOPHLEBITIS 4 0.0011
449 CYTOMEGALOVIRUS INFECTION REACTIVATION 5 0.0011
450 GASTROINTESTINAL DISORDER 101 0.0011
451 BODY TEMPERATURE INCREASED 23 0.0011
452 CYTOMEGALOVIRUS VIRAEMIA 5 0.0011
453 HAEMATOCRIT DECREASED 22 0.0011
454 BLOOD PHOSPHORUS INCREASED 3 0.0011
455 CUTANEOUS VASCULITIS 4 0.0011
456 HEPATITIS 28 0.0011
457 MOUTH HAEMORRHAGE 8 0.0011
458 HYPOTHERMIA 11 0.0011
459 STEVENS-JOHNSON SYNDROME 24 0.0011
460 STATUS EPILEPTICUS 12 0.0011
461 CIRCULATORY COLLAPSE 18 0.0011
462 SPUTUM DISCOLOURED 10 0.0011
463 RENAL FAILURE ACUTE 44 0.0010
464 ADENOVIRUS INFECTION 3 0.0010
465 RALES 6 0.0010
466 RENAL FAILURE 136 0.0010
467 SKIN LESION 28 0.0010
468 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 6 0.0010
469 ORGANISING PNEUMONIA 5 0.0010
470 MENTAL STATUS CHANGES 28 0.0010
471 HAEMOLYTIC ANAEMIA 9 0.0010
472 ASPIRATION 11 0.0010
473 PROTEIN URINE PRESENT 5 0.0010
474 SKIN REACTION 14 0.0010
475 CRANIOCEREBRAL INJURY 3 0.0010
476 DYSPHORIA 5 0.0010
477 TOE AMPUTATION 5 0.0010
478 BRAIN NATRIURETIC PEPTIDE INCREASED 3 0.0010
479 LEG AMPUTATION 4 0.0010
480 GASTROINTESTINAL HAEMORRHAGE 81 0.0010
481 INFUSION SITE EXTRAVASATION 6 0.0010
482 SKIN NECROSIS 5 0.0010
483 FAILURE TO THRIVE 5 0.0010
484 SECRETION DISCHARGE 12 0.0010
485 SWELLING OF EYELID 6 0.0010
486 BLOOD LACTIC ACID INCREASED 5 0.0009
487 LOWER GASTROINTESTINAL HAEMORRHAGE 7 0.0009
488 BILE DUCT STONE 3 0.0009
489 HEPATIC CYTOLYSIS 12 0.0009
490 ABSCESS LIMB 4 0.0009
491 DRUG INTERACTION 148 0.0009
492 CELLULITIS 47 0.0009
493 VOMITING 438 0.0009
494 MYOCLONUS 11 0.0009
495 DRUG INTOLERANCE 89 0.0009
496 WOUND INFECTION 10 0.0009
497 HYPOKALAEMIA 42 0.0009
498 RESPIRATORY DISTRESS 25 0.0009
499 RESPIRATORY RATE INCREASED 8 0.0009
500 RASH ERYTHEMATOUS 43 0.0009
501 MENINGITIS 6 0.0009
502 PRODUCT USE IN UNAPPROVED INDICATION 222 0.0009
503 UPPER GASTROINTESTINAL HAEMORRHAGE 15 0.0009
504 RETCHING 19 0.0009
505 ILEUS 11 0.0009
506 CHOLECYSTITIS ACUTE 5 0.0009
507 DRUG LEVEL ABOVE THERAPEUTIC 4 0.0009
508 NEPHROGENIC ANAEMIA 4 0.0009
509 PETECHIAE 9 0.0009
510 NEUTROPENIA 117 0.0009
511 HEPATIC STEATOSIS 16 0.0009
512 BRONCHIOLITIS 3 0.0009
513 VENTRICULAR TACHYCARDIA 14 0.0008
514 HYPOCALCAEMIA 16 0.0008
515 NEUROPATHY PERIPHERAL 80 0.0008
516 NAUSEA 665 0.0008
517 SUPRAVENTRICULAR TACHYCARDIA 8 0.0008
518 CONDITION AGGRAVATED 253 0.0008
519 GANGRENE 5 0.0008
520 HYPOPHAGIA 21 0.0008
521 THROMBOTIC MICROANGIOPATHY 8 0.0008
522 NO THERAPEUTIC RESPONSE 10 0.0008
523 RENAL TUBULAR NECROSIS 8 0.0008
524 FEBRILE NEUTROPENIA 54 0.0008
525 DERMATITIS 17 0.0008
526 STAPHYLOCOCCAL SEPSIS 4 0.0008
527 FUNGAL INFECTION 27 0.0008
528 ABDOMINAL TENDERNESS 4 0.0008
529 OLIGURIA 5 0.0008
530 INTESTINAL PERFORATION 9 0.0008
531 PNEUMONIA ASPIRATION 20 0.0008
532 EPSTEIN-BARR VIRUS INFECTION 5 0.0008
533 HYPONATRAEMIA 45 0.0008
534 RENAL INJURY 23 0.0008
535 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 6 0.0008
536 HERPES SIMPLEX 5 0.0008
537 ELECTROCARDIOGRAM ABNORMAL 6 0.0008
538 HYPOGAMMAGLOBULINAEMIA 5 0.0008
539 CHOLECYSTITIS 9 0.0008
540 PRODUCTIVE COUGH 36 0.0008
541 CEREBRAL ATROPHY 3 0.0008
542 CANDIDIASIS 3 0.0007
543 WHITE BLOOD CELL COUNT DECREASED 81 0.0007
544 ATRIOVENTRICULAR BLOCK COMPLETE 5 0.0007
545 FUNGAL SKIN INFECTION 3 0.0007
546 RED BLOOD CELL COUNT DECREASED 21 0.0007
547 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 7 0.0007
548 POLYURIA 6 0.0007
549 DEMYELINATION 3 0.0007
550 EXTRAVASATION 3 0.0007
551 OXYGEN SATURATION DECREASED 41 0.0007
552 DRUG LEVEL BELOW THERAPEUTIC 4 0.0007
553 SINUS BRADYCARDIA 7 0.0007
554 PLEURAL EFFUSION 44 0.0007
555 ENCEPHALITIS 5 0.0007
556 NECROSIS 4 0.0007
557 FISTULA 8 0.0007
558 ANAEMIA 135 0.0007
559 CARDIAC ARREST 58 0.0007
560 MYDRIASIS 9 0.0007
561 NEUTROPENIC SEPSIS 5 0.0007
562 NEUROLOGICAL SYMPTOM 4 0.0007
563 CYTOKINE RELEASE SYNDROME 14 0.0007
564 INFECTION 101 0.0007
565 UNRESPONSIVE TO STIMULI 18 0.0007
566 CARDIOGENIC SHOCK 10 0.0007
567 SKIN ATROPHY 4 0.0007
568 MYOPATHY 6 0.0007
569 DISEASE RECURRENCE 33 0.0007
570 DERMATITIS BULLOUS 5 0.0007
571 METABOLIC DISORDER 4 0.0007
572 FAECES SOFT 5 0.0007
573 URINE OUTPUT DECREASED 6 0.0007
574 PERIPHERAL SENSORY NEUROPATHY 4 0.0007
575 PURPURA 6 0.0007
576 ENERGY INCREASED 4 0.0007
577 VENTRICULAR EXTRASYSTOLES 7 0.0007
578 DRUG INEFFECTIVE 883 0.0007
579 TYPE 1 DIABETES MELLITUS 4 0.0007
580 HYPOTENSION 133 0.0007
581 PLATELET COUNT ABNORMAL 4 0.0007
582 COMA 31 0.0007
583 HYPOACUSIS 28 0.0006
584 ARTHRITIS INFECTIVE 3 0.0006
585 CHOLANGITIS 4 0.0006
586 APHONIA 9 0.0006
587 HEPATIC ENCEPHALOPATHY 6 0.0006
588 HAEMOGLOBIN DECREASED 66 0.0006
589 TUBULOINTERSTITIAL NEPHRITIS 12 0.0006
590 PULMONARY HAEMORRHAGE 5 0.0006
591 MELAENA 14 0.0006
592 HYPOXIA 22 0.0006
593 SKIN INFECTION 7 0.0006
594 POOR QUALITY SLEEP 13 0.0006
595 LIP SWELLING 20 0.0006
596 DRUG TOLERANCE 3 0.0006
597 COLITIS ISCHAEMIC 4 0.0006
598 DRUG LEVEL DECREASED 6 0.0006
599 AMMONIA INCREASED 3 0.0006
600 PYREXIA 203 0.0006
601 LUNG INFECTION 9 0.0006
602 EJECTION FRACTION DECREASED 9 0.0006
603 PROTEINURIA 11 0.0006
604 RESPIRATORY TRACT INFECTION 15 0.0006
605 DISEASE PROGRESSION 68 0.0006
606 CARDIO-RESPIRATORY ARREST 24 0.0006
607 THERAPY INTERRUPTED 41 0.0006
608 IMMUNOSUPPRESSION 5 0.0006
609 ULCER 9 0.0006
610 SINUS TACHYCARDIA 8 0.0006
611 CHEILITIS 3 0.0006
612 OPTIC NEURITIS 5 0.0005
613 DYSPHONIA 32 0.0005
614 GENERAL PHYSICAL HEALTH DETERIORATION 63 0.0005
615 GRAND MAL CONVULSION 5 0.0005
616 DIARRHOEA HAEMORRHAGIC 5 0.0005
617 PNEUMONIA 172 0.0005
618 PULMONARY CONGESTION 7 0.0005
619 BLOOD SODIUM DECREASED 10 0.0005
620 TACHYCARDIA 47 0.0005
621 TROPONIN INCREASED 4 0.0005
622 INTERNAL HAEMORRHAGE 6 0.0005
623 ACIDOSIS 4 0.0005
624 DIARRHOEA 336 0.0005
625 HAEMORRHAGE 54 0.0005
626 ACUTE MYELOID LEUKAEMIA 8 0.0005
627 BODY TEMPERATURE DECREASED 5 0.0005
628 ALTERED STATE OF CONSCIOUSNESS 11 0.0005
629 DEPRESSED LEVEL OF CONSCIOUSNESS 20 0.0005
630 FURUNCLE 4 0.0005
631 HYPERLIPIDAEMIA 6 0.0005
632 RESPIRATORY DISORDER 15 0.0005
633 RASH PRURITIC 27 0.0005
634 MYASTHENIA GRAVIS 4 0.0005
635 ADRENAL INSUFFICIENCY 6 0.0005
636 ABDOMINAL PAIN 115 0.0005
637 RASH PAPULAR 11 0.0005
638 NEUTROPHIL COUNT DECREASED 20 0.0005
639 SMALL INTESTINAL OBSTRUCTION 6 0.0005
640 HICCUPS 4 0.0005
641 BLISTER 27 0.0005
642 MOUTH ULCERATION 10 0.0005
643 LUNG DISORDER 23 0.0005
644 SEROTONIN SYNDROME 9 0.0005
645 PRODUCT CONTAINER ISSUE 4 0.0005
646 ANAPHYLACTIC SHOCK 12 0.0005
647 DECREASED APPETITE 108 0.0005
648 UNEVALUABLE EVENT 35 0.0005
649 PYELONEPHRITIS 4 0.0005
650 FAECES DISCOLOURED 10 0.0005
651 INSURANCE ISSUE 7 0.0005
652 RASH MACULAR 16 0.0005
653 CHOLELITHIASIS 15 0.0005
654 LOCALISED INFECTION 11 0.0005
655 PULMONARY OEDEMA 20 0.0004
656 HAEMARTHROSIS 4 0.0004
657 THERAPY NON-RESPONDER 20 0.0004
658 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 13 0.0004
659 HOSPITALISATION 68 0.0004
660 BLOOD LACTATE DEHYDROGENASE INCREASED 7 0.0004
661 ABDOMINAL DISCOMFORT 74 0.0004
662 HYPERGLYCAEMIA 16 0.0004
663 BLOOD PRESSURE DECREASED 29 0.0004
664 NIGHT SWEATS 14 0.0004
665 BLOOD POTASSIUM INCREASED 7 0.0004
666 EXTRASYSTOLES 3 0.0004
667 FLANK PAIN 4 0.0004
668 IMPAIRED HEALING 14 0.0004
669 EPILEPSY 13 0.0004
670 ARTERIOSCLEROSIS 4 0.0004
671 HAEMATOMA 11 0.0004
672 DIALYSIS 6 0.0004
673 ABDOMINAL DISTENSION 44 0.0004
674 ATRIAL FIBRILLATION 41 0.0004
675 HYPERSENSITIVITY 78 0.0004
676 CHEST DISCOMFORT 43 0.0004
677 HYPERCHOLESTEROLAEMIA 4 0.0004
678 RASH 180 0.0004
679 ORAL HERPES 8 0.0004
680 ASCITES 12 0.0004
681 CHRONIC KIDNEY DISEASE 31 0.0004
682 FREQUENT BOWEL MOVEMENTS 11 0.0004
683 VITREOUS FLOATERS 4 0.0004
684 BLINDNESS TRANSIENT 3 0.0004
685 CARDIOMEGALY 5 0.0004
686 BLOOD PRESSURE DIASTOLIC DECREASED 3 0.0004
687 PSYCHOTIC DISORDER 12 0.0004
688 OEDEMA 22 0.0004
689 PALLOR 11 0.0004
690 HAEMATOCHEZIA 22 0.0004
691 FULL BLOOD COUNT DECREASED 8 0.0004
692 HAEMATEMESIS 10 0.0004
693 DRY THROAT 4 0.0004
694 TOOTH ABSCESS 4 0.0004
695 CHILLS 46 0.0004
696 CARDIAC FAILURE 31 0.0004
697 INTENTIONAL DOSE OMISSION 11 0.0004
698 NERVOUS SYSTEM DISORDER 12 0.0004
699 END STAGE RENAL DISEASE 7 0.0004
700 DEATH 329 0.0004
701 WEIGHT DECREASED 106 0.0004
702 ORAL CANDIDIASIS 5 0.0004
703 SCRATCH 4 0.0004
704 RESPIRATORY TRACT CONGESTION 6 0.0004
705 BLOOD DISORDER 3 0.0004
706 CARDIAC FAILURE CONGESTIVE 30 0.0004
707 COLITIS 14 0.0004
708 CEREBRAL INFARCTION 9 0.0004
709 PNEUMONITIS 10 0.0004
710 CONVULSION 21 0.0004
711 LETHARGY 21 0.0004
712 POST PROCEDURAL COMPLICATION 7 0.0004
713 ABDOMINAL PAIN UPPER 75 0.0004
714 DYSGEUSIA 27 0.0004
715 HEART RATE INCREASED 36 0.0004
716 EMBOLISM 3 0.0004
717 PROCEDURAL PAIN 10 0.0004
718 VENTRICULAR FIBRILLATION 4 0.0004
719 BLOOD TEST ABNORMAL 5 0.0004
720 CHROMATURIA 8 0.0004
721 MITRAL VALVE INCOMPETENCE 4 0.0004
722 DYSURIA 13 0.0004
723 MYOCARDIAL ISCHAEMIA 4 0.0004
724 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 25 0.0004
725 SCAB 4 0.0004
726 MYOCARDITIS 4 0.0003
727 INFLAMMATION 18 0.0003
728 PRODUCT USE ISSUE 65 0.0003
729 DYSPNOEA EXERTIONAL 13 0.0003
730 TASTE DISORDER 7 0.0003
731 EYELID OEDEMA 4 0.0003
732 GASTROENTERITIS 5 0.0003
733 BLOOD TRIGLYCERIDES INCREASED 6 0.0003
734 BRADYCARDIA 18 0.0003
735 LIVER DISORDER 15 0.0003
736 ATAXIA 4 0.0003
737 CARDIOTOXICITY 3 0.0003
738 GASTROINTESTINAL INFECTION 3 0.0003
739 COUGH 93 0.0003
740 APHASIA 10 0.0003
741 DEHYDRATION 44 0.0003
742 INCORRECT DOSE ADMINISTERED 75 0.0003
743 RESPIRATORY ARREST 9 0.0003
744 AGEUSIA 8 0.0003
745 OEDEMA PERIPHERAL 39 0.0003
746 HEPATIC CIRRHOSIS 6 0.0003
747 CYANOSIS 5 0.0003
748 PALPITATIONS 37 0.0003
749 PULMONARY EMBOLISM 30 0.0003
750 CONFUSIONAL STATE 51 0.0003
751 CARDIOVASCULAR DISORDER 8 0.0003
752 DYSPNOEA 178 0.0003
753 EYE INFLAMMATION 3 0.0003
754 TOXICITY TO VARIOUS AGENTS 53 0.0003
755 RASH GENERALISED 8 0.0003
756 INTENTIONAL PRODUCT USE ISSUE 27 0.0003
757 DEEP VEIN THROMBOSIS 20 0.0003
758 PERICARDIAL EFFUSION 7 0.0003
759 GENERALISED TONIC-CLONIC SEIZURE 5 0.0003
760 MENTAL DISORDER 13 0.0003
761 GASTROOESOPHAGEAL REFLUX DISEASE 24 0.0003
762 EMPHYSEMA 3 0.0003
763 FACE OEDEMA 5 0.0003
764 DRUG TOXICITY 4 0.0003
765 IMPAIRED GASTRIC EMPTYING 4 0.0003
766 HALLUCINATION 22 0.0003
767 PERIPHERAL COLDNESS 4 0.0003
768 ABNORMAL DREAMS 8 0.0003
769 SWOLLEN TONGUE 9 0.0003
770 ORAL DISCOMFORT 4 0.0003
771 LOWER RESPIRATORY TRACT INFECTION 13 0.0003
772 HEART RATE DECREASED 10 0.0003
773 NEPHROLITHIASIS 13 0.0003
774 BREAST PAIN 3 0.0003
775 PRURITUS 108 0.0003
776 GALLBLADDER DISORDER 5 0.0003
777 PARAESTHESIA ORAL 4 0.0003
778 ABDOMINAL PAIN LOWER 7 0.0003
779 PRODUCT PRESCRIBING ISSUE 6 0.0003
780 THROMBOSIS 22 0.0003
781 GASTROINTESTINAL PAIN 3 0.0003
782 ERYTHEMA 56 0.0003
783 ILLNESS 28 0.0003
784 INFUSION RELATED REACTION 18 0.0003
785 ACUTE MYOCARDIAL INFARCTION 8 0.0003
786 CARDIOMYOPATHY 4 0.0003
787 SEIZURE 31 0.0003
788 HAEMORRHAGE INTRACRANIAL 4 0.0003
789 MUCOSAL INFLAMMATION 7 0.0003
790 BLOOD CALCIUM DECREASED 3 0.0003
791 CONTRAINDICATED PRODUCT ADMINISTERED 8 0.0003
792 DYSPHAGIA 25 0.0003
793 HAEMATURIA 9 0.0003
794 SWELLING FACE 17 0.0003
795 MUSCLE TWITCHING 6 0.0003
796 DELIRIUM 9 0.0003
797 BLOOD CHOLESTEROL INCREASED 12 0.0003
798 EAR PAIN 5 0.0003
799 THERAPY PARTIAL RESPONDER 4 0.0003
800 COVID-19 PNEUMONIA 3 0.0003
801 PRODUCT USE COMPLAINT 4 0.0003
802 ARRHYTHMIA 12 0.0003
803 SINUS DISORDER 5 0.0003
804 URINARY TRACT INFECTION 43 0.0003
805 BLOOD PRESSURE ABNORMAL 5 0.0003
806 URTICARIA 42 0.0003
807 WOUND 7 0.0003
808 PRODUCT ADMINISTRATION ERROR 5 0.0002
809 PRESYNCOPE 6 0.0002
810 NEURALGIA 6 0.0002
811 VERTIGO 15 0.0002
812 PERICARDITIS 4 0.0002
813 HEMIPARESIS 4 0.0002
814 WHEEZING 14 0.0002
815 ADVERSE DRUG REACTION 21 0.0002
816 SCAR 4 0.0002
817 ADVERSE REACTION 3 0.0002
818 SYSTEMIC LUPUS ERYTHEMATOSUS 8 0.0002
819 BLOOD PRESSURE INCREASED 34 0.0002
820 DRY MOUTH 18 0.0002
821 RESTLESS LEGS SYNDROME 4 0.0002
822 BONE DISORDER 4 0.0002
823 MALAISE 96 0.0002
824 HYPERHIDROSIS 28 0.0002
825 FEELING COLD 6 0.0002
826 CARPAL TUNNEL SYNDROME 3 0.0002
827 BLINDNESS UNILATERAL 3 0.0002
828 ACCIDENTAL UNDERDOSE 3 0.0002
829 BALANCE DISORDER 18 0.0002
830 ERUCTATION 4 0.0002
831 INTERSTITIAL LUNG DISEASE 10 0.0002
832 FLUID OVERLOAD 3 0.0002
833 BLOOD PRESSURE SYSTOLIC INCREASED 4 0.0002
834 LABORATORY TEST ABNORMAL 6 0.0002
835 DYSPEPSIA 20 0.0002
836 HYPERTENSION 43 0.0002
837 DISORIENTATION 8 0.0002
838 TREATMENT NONCOMPLIANCE 11 0.0002
839 BLOOD POTASSIUM DECREASED 6 0.0002
840 ASTHENIA 75 0.0002
841 ANAPHYLACTIC REACTION 11 0.0002
842 CORONARY ARTERY DISEASE 6 0.0002
843 ECONOMIC PROBLEM 3 0.0002
844 FATIGUE 154 0.0002
845 FEEDING DISORDER 4 0.0002
846 DISCOMFORT 12 0.0002
847 CEREBRAL HAEMORRHAGE 7 0.0002
848 RIB FRACTURE 4 0.0002
849 CHEST PAIN 36 0.0002
850 SKIN ULCER 5 0.0002
851 RENAL DISORDER 9 0.0002
852 PULMONARY HYPERTENSION 4 0.0002
853 BRAIN FOG 3 0.0002
854 BLOOD GLUCOSE INCREASED 36 0.0002
855 PRODUCT DOSE OMISSION ISSUE 56 0.0002
856 ANHEDONIA 5 0.0002
857 SKIN EXFOLIATION 16 0.0002
858 VISION BLURRED 26 0.0002
859 EPISTAXIS 14 0.0002
860 FEAR 5 0.0002
861 SINUSITIS 19 0.0002
862 THROAT TIGHTNESS 5 0.0002
863 LIMB INJURY 5 0.0002
864 OROPHARYNGEAL PAIN 17 0.0002
865 SYNCOPE 18 0.0002
866 SKIN DISORDER 6 0.0002
867 CONSTIPATION 39 0.0002
868 THROAT IRRITATION 8 0.0002
869 PAIN IN JAW 5 0.0002
870 PRODUCT AVAILABILITY ISSUE 4 0.0002
871 DIZZINESS 87 0.0002
872 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 9 0.0002
873 ECZEMA 9 0.0002
874 SWELLING 16 0.0002
875 SOMNOLENCE 33 0.0002
876 TREMOR 27 0.0002
877 PERIPHERAL SWELLING 25 0.0002
878 CONJUNCTIVITIS 3 0.0002
879 EXTRAPYRAMIDAL DISORDER 4 0.0002
880 MUSCULAR WEAKNESS 18 0.0002
881 BLOOD URINE PRESENT 3 0.0002
882 HEAD INJURY 5 0.0002
883 INSOMNIA 42 0.0002
884 FEELING JITTERY 3 0.0002
885 FLUID RETENTION 8 0.0002
886 THERAPY CESSATION 8 0.0002
887 MOVEMENT DISORDER 5 0.0002
888 SURGERY 9 0.0002
889 GASTRITIS 4 0.0002
890 UPPER RESPIRATORY TRACT INFECTION 7 0.0002
891 VISUAL ACUITY REDUCED 5 0.0002
892 AGITATION 11 0.0001
893 TRANSIENT ISCHAEMIC ATTACK 5 0.0001
894 DYSKINESIA 6 0.0001
895 BACK PAIN 34 0.0001
896 BLOOD GLUCOSE DECREASED 7 0.0001
897 DIABETES MELLITUS 11 0.0001
898 ARTHROPATHY 8 0.0001
899 LYMPHADENOPATHY 5 0.0001
900 FLATULENCE 8 0.0001
901 EATING DISORDER 3 0.0001
902 LOSS OF CONSCIOUSNESS 18 0.0001
903 HYPERSOMNIA 4 0.0001
904 HERPES ZOSTER 8 0.0001
905 CRYING 5 0.0001
906 BRONCHITIS 10 0.0001
907 DRY SKIN 18 0.0001
908 EYE SWELLING 5 0.0001
909 HYPOAESTHESIA 20 0.0001
910 INTESTINAL OBSTRUCTION 5 0.0001
911 COVID-19 23 0.0001
912 HEADACHE 82 0.0001
913 FEELING HOT 8 0.0001
914 ADVERSE EVENT 12 0.0001
915 VISUAL IMPAIRMENT 16 0.0001
916 CARDIAC DISORDER 12 0.0001
917 INJURY 9 0.0001
918 NECK PAIN 7 0.0001
919 OVERDOSE 27 0.0001
920 EYE DISORDER 4 0.0001
921 POLLAKIURIA 5 0.0001
922 OSTEOARTHRITIS 5 0.0001
923 CATARACT 7 0.0001
924 DIPLOPIA 3 0.0001
925 NEOPLASM PROGRESSION 4 0.0001
926 CONTUSION 11 0.0001
927 BURNING SENSATION 8 0.0001
928 ANGIOEDEMA 5 0.0001
929 UNDERDOSE 8 0.0001
930 ANXIETY 31 0.0001
931 FLUSHING 11 0.0001
932 PARAESTHESIA 17 0.0001
933 MALIGNANT NEOPLASM PROGRESSION 11 0.0001
934 DEMENTIA 3 0.0001
935 DYSARTHRIA 4 0.0001
936 MYALGIA 18 0.0001
937 ANGINA PECTORIS 3 0.0001
938 GAIT DISTURBANCE 20 0.0001
939 FEELING ABNORMAL 25 0.0001
940 DYSSTASIA 3 0.0001
941 MATERNAL EXPOSURE DURING PREGNANCY 9 0.0001
942 ILL-DEFINED DISORDER 6 0.0001
943 MYOCARDIAL INFARCTION 17 0.0001
944 OSTEOPOROSIS 4 0.0001
945 MUSCULOSKELETAL PAIN 5 0.0001
946 DEPRESSED MOOD 5 0.0001
947 CYSTITIS 3 0.0001
948 HOT FLUSH 7 0.0001
949 AMNESIA 6 0.0001
950 COLITIS ULCERATIVE 4 0.0001
951 WEIGHT INCREASED 20 0.0001
952 EYE PRURITUS 3 0.0001
953 PAIN IN EXTREMITY 26 0.0001
954 NASAL CONGESTION 5 0.0001
955 DEPRESSION 19 0.0001
956 JOINT SWELLING 10 0.0001
957 STOMATITIS 5 0.0001
958 DEVICE ISSUE 7 0.0001
959 RHINORRHOEA 5 0.0001
960 DRUG DOSE OMISSION BY DEVICE 6 0.0001
961 NERVOUSNESS 4 0.0001
962 FALL 25 0.0001
963 BLINDNESS 3 0.0001
964 ARTHRALGIA 30 0.0001
965 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 13 0.0001
966 MEDICATION ERROR 4 0.0001
967 NO ADVERSE EVENT 13 0.0001
968 ASTHMA 8 0.0001
969 DEVICE LEAKAGE 3 0.0001
970 DEVICE DISLOCATION 3 0.0001
971 ACNE 5 0.0001
972 SUICIDAL IDEATION 6 0.0001
973 MUSCLE SPASMS 12 0.0001
974 EXPOSURE DURING PREGNANCY 4 0.0001
975 PAIN 38 0.0001
976 DRY EYE 3 0.0001
977 MUSCULOSKELETAL STIFFNESS 5 0.0001
978 EYE PAIN 3 0.0001
979 CEREBROVASCULAR ACCIDENT 9 0.0001
980 MIGRAINE 5 0.0001
981 BONE PAIN 3 0.0001
982 ALOPECIA 9 0.0000
983 INFLUENZA 5 0.0000
984 PRODUCT QUALITY ISSUE 6 0.0000
985 ARTHRITIS 3 0.0000
986 NASOPHARYNGITIS 7 0.0000
987 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 7 0.0000
988 MEMORY IMPAIRMENT 4 0.0000
989 EMOTIONAL DISTRESS 3 0.0000
990 DRUG DEPENDENCE 3 0.0000
991 INJECTION SITE PAIN 5 0.0000